Syra Health (SYRA) plans to delist from Nasdaq with the last day of share trading expected around April 21.
The shares are expected to be listed on the OTC market until a possible relisting on a national securities exchange, Syra Health said Tuesday in a statement.
"The company will be better enabled to enhance operational efficiencies, optimize its financial health and generate sustainable long-term growth" while reducing costs associated with a Nasdaq listing, according to the statement.
The company plans to file a delisting notification with the Securities and Exchange Commission on April 11.
Syra Health received a noncompliance notice from Nasdaq in October for failing to meet the minimum $1 bid price for continued listing. The company had until April 16 to regain compliance.
Shares of the company fell 37% in after-hours trading.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。